These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 29860111)

  • 1. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.
    Kraef C; Schlein C; Hiller J; Westhölter D; Denzer U; Horvatits T; Peine S; Lohse AW; Lütgehetmann M; Polywka S; Pischke S
    J Clin Virol; 2018 Aug; 105():26-30. PubMed ID: 29860111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
    Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
    Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria.
    Fischer C; Hofmann M; Danzer M; Hofer K; Kaar J; Gabriel C
    PLoS One; 2015; 10(3):e0119576. PubMed ID: 25751574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India.
    Katiyar H; Goel A; Sonker A; Yadav V; Sapun S; Chaudhary R; Aggarwal R
    Indian J Gastroenterol; 2018 Jul; 37(4):342-346. PubMed ID: 30159666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E Virus Infection in Voluntary Blood Donors in the Russian Federation.
    Potemkin IA; Kyuregyan KK; Karlsen AA; Isaeva OV; Kichatova VS; Lopatukhina MA; Asadi Mobarkhan FA; Zlobina AG; Zheltobriukh AV; Bocharova KA; Belyakova VV; Rassolova SV; Ivanova NV; Solonin SA; Bazhenov AI; Godkov MA; Mikhailov MI
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.
    Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I
    Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
    Gotanda Y; Iwata A; Ohnuma H; Yoshikawa A; Mizoguchi H; Endo K; Takahashi M; Okamoto H
    J Med Virol; 2007 Jun; 79(6):734-42. PubMed ID: 17457924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Hepatitis E Virus Infections in Asymptomatic Persons.
    Plümers R; Dreier J; Knabbe C; Steinmann E; Todt D; Vollmer T
    Emerg Infect Dis; 2024 May; 30(5):934-940. PubMed ID: 38666600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays.
    Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27556482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis E virus infection in population of non-remunerate blood donors in Shaoxing].
    Sang LY; Zhuang PF; Fu LQ; Liu Y; Ge SX; Zhang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):29-31. PubMed ID: 17429528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E.
    Arankalle VA; Chobe LP
    Vox Sang; 2000; 79(2):72-4. PubMed ID: 11054043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.
    Norder H; Karlsson M; Mellgren Å; Konar J; Sandberg E; Lasson A; Castedal M; Magnius L; Lagging M
    J Clin Microbiol; 2016 Mar; 54(3):549-55. PubMed ID: 26659210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E virus: can it be transmitted parenterally?
    Arankalle VA; Chobe LP
    J Viral Hepat; 1999 Mar; 6(2):161-4. PubMed ID: 10607228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.
    Niederhauser C; Gowland P; Widmer N; Amar El Dusouqui S; Mattle-Greminger M; Gottschalk J; Frey BM
    Viruses; 2024 May; 16(5):. PubMed ID: 38793625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China.
    Wang M; He M; Wu B; Ke L; Han T; Wang J; Shan H; Ness P; Guo N; Liu Y; Nelson KE
    Transfusion; 2017 Feb; 57(2):273-279. PubMed ID: 28194856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus infection in the Irish blood donor population.
    O'Riordan J; Boland F; Williams P; Donnellan J; Hogema BM; Ijaz S; Murphy WG
    Transfusion; 2016 Nov; 56(11):2868-2876. PubMed ID: 27522065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors.
    Wen GP; Chen CR; Song XY; Tang ZM; Ji WF; Wang SL; Zhang K; Zhang J; Ou SH; Zheng ZZ; Xia NS
    Emerg Microbes Infect; 2018 Jul; 7(1):125. PubMed ID: 29977038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
    Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
    J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
    Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
    J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.